Baolingbao Biology Co.,Ltd. (002286.SZ)
CNY 7.94
(-1.24%)
CNY 7.94
(-1.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 282.28 Million | 30.82 Million | 206.26 Million | 398.45 Million | 153.95 Million | 133.05 Million |
| Net Income | 53.96 Million | 133.16 Million | 201.57 Million | 49.86 Million | 34.92 Million | 42.64 Million |
| Depreciation & Amortization | 122.74 Million | 105.62 Million | 104.98 Million | 96.26 Million | 98.22 Million | 83.73 Million |
| Deferred income taxes | -588.35 Thousand | -34.19 Thousand | -1.14 Million | -158.09 Thousand | 908.36 Thousand | -1.06 Million |
| Stock-based compensation | -6.27 Million | 9.59 Million | 3.37 Million | - | - | - |
| Change in working capital | 80.94 Million | -224.95 Million | -117.22 Million | 220.86 Million | -23.96 Million | -27.27 Million |
| Other non-cash items | 24.62 Million | 7.42 Million | 14.7 Million | 31.47 Million | 44.76 Million | 33.94 Million |
| Investing Cash Flow | -148.09 Million | -129.68 Million | -175.5 Million | -121.27 Million | -43.82 Million | -292.18 Million |
| Investments in PPE | -152.23 Million | -254.54 Million | -92.84 Million | -131.93 Million | -95.45 Million | -173.7 Million |
| Acquisitions | 94.3 Thousand | 64.68 Thousand | 831.14 Thousand | 607.1 Thousand | 1.57 Million | 232.52 Thousand |
| Investment purchases | -94.3 Thousand | -64.68 Thousand | -101.43 Million | -607.1 Thousand | -924.3 Thousand | -212.38 Million |
| Sales/Maturities of investments | 4.04 Million | 124.8 Million | 17.94 Million | 10.05 Million | 47.86 Million | 4.5 Million |
| Other Investing Activities | 94.3 Thousand | 64.68 Thousand | 1.12 | 607.1 Thousand | 3.11 Million | 89.15 Million |
| Financing Cash Flow | -270.14 Million | 63.14 Million | 134.37 Million | -202.35 Million | -209.93 Million | 276.47 Million |
| Debt repayment | -497.17 Million | -435.79 Million | -298.43 Million | -604.95 Million | -908 Million | -295 Million |
| Dividends payments | -29.59 Million | -22.3 Million | -22.15 Million | -11.07 Million | -11.07 Million | -61.22 Million |
| Common Stock Repurchased | -7.27 Million | -691.02 Thousand | - | - | - | - |
| Common Stock Issuance | - | 691.01 Thousand | - | - | - | - |
| Other Financing Activities | 276.79 Million | 551.45 Million | 471.74 Million | 426.9 Million | 740.33 Million | 632.69 Million |
| Accounts receivables | 16.25 Million | 66.21 Million | -84.74 Million | 96.34 Million | -71.54 Million | -37.61 Million |
| Accounts payables | 15.49 Million | -237.65 Million | 39.34 Million | 155.12 Million | 12.47 Million | 60.16 Million |
| Inventory | 49.79 Million | -53.48 Million | -70.67 Million | -30.44 Million | 34.19 Million | -48.76 Million |
| Other working capital | -588.35 Thousand | -34.19 Thousand | -1.14 Million | -158.09 Thousand | 908.36 Thousand | 21.48 Million |
| Cash at beginning of period | 374.89 Million | 406.89 Million | 245.05 Million | 174.48 Million | 273.27 Million | 155.67 Million |
| Cash at end of period | 239.03 Million | 374.89 Million | 406.89 Million | 245.05 Million | 174.48 Million | 273.27 Million |
| Capital Expenditure | -152.23 Million | -254.54 Million | -92.84 Million | -131.93 Million | -95.45 Million | -173.7 Million |
| Effect of forex changes on cash | 90.37 Thousand | 3.72 Million | -3.28 Million | -4.26 Million | 1.01 Million | 263.49 Thousand |
| Net cash flow / Change in cash | -135.86 Million | -31.99 Million | 161.83 Million | 70.56 Million | -98.78 Million | 117.6 Million |
| Free Cash Flow | 130.05 Million | -223.72 Million | 113.42 Million | 266.52 Million | 58.49 Million | -40.65 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 31.73 Million | 46.16 Million | 23.16 Million | 7.98 Million | 53.96 Million | 13.22 Million |
| Depreciation & Amortization | - | 32.63 Million | 32.63 Million | 31.52 Million | 122.74 Million | 31.52 Million |
| Deferred income taxes | - | - | - | -42.9 Million | -588.35 Thousand | -108.51 Million |
| Stock-based compensation | - | - | - | -6.27 Million | -6.27 Million | -2.68 Million |
| Change in working capital | - | -108.85 Million | - | 49.17 Million | 80.94 Million | 48.16 Million |
| Other non-cash items | 58.17 Million | 8.32 Million | -37.61 Million | 38.39 Million | 24.62 Million | 172.27 Million |
| Investing Cash Flow | -41.42 Million | -33.5 Million | -2.72 Million | -27.65 Million | -148.09 Million | -32.66 Million |
| Investments in PPE | -41.42 Million | -33.5 Million | -28.46 Million | -30.46 Million | -152.23 Million | -32.66 Million |
| Acquisitions | - | - | - | 83.41 Thousand | 94.3 Thousand | 1100.00 |
| Investment purchases | - | - | - | -83.41 Thousand | -94.3 Thousand | - |
| Sales/Maturities of investments | - | - | 25.73 Million | 2.73 Million | 4.04 Million | - |
| Other Investing Activities | - | - | 25.73 Million | 83.41 Thousand | 94.3 Thousand | 1100.00 |
| Financing Cash Flow | -2.85 Million | 5.21 Million | 10.81 Million | -83.73 Million | -270.14 Million | -136.77 Million |
| Debt repayment | -200 Thousand | -9.7 Million | -50.6 Million | -168.98 Million | -497.17 Million | -140.69 Million |
| Dividends payments | -3.05 Million | -3.67 Million | -32.94 Million | -29.59 Million | -29.59 Million | -4.6 Million |
| Common Stock Repurchased | 6.84 Million | -6.84 Million | - | -7.27 Million | -7.27 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -9.89 Million | 3.16 Million | -39.78 Million | 88.86 Million | 276.79 Million | 8.53 Million |
| Accounts receivables | - | -54.36 Million | - | 16.25 Million | 16.25 Million | 30.69 Million |
| Accounts payables | - | - | - | - | 15.49 Million | - |
| Inventory | - | -54.49 Million | - | 49.79 Million | 49.79 Million | 17.47 Million |
| Other working capital | - | - | - | -16.87 Million | -588.35 Thousand | - |
| Cash at beginning of period | 230.05 Million | 237.75 Million | 242.73 Million | 274.95 Million | 374.89 Million | 290.24 Million |
| Cash at end of period | 275.17 Million | 233.75 Million | 237.75 Million | 239.03 Million | 239.03 Million | 274.95 Million |
| Capital Expenditure | -41.42 Million | -33.5 Million | -28.46 Million | -30.46 Million | -152.23 Million | -32.66 Million |
| Effect of forex changes on cash | -526.48 Thousand | 2.43 Million | 1.37 Million | -2.41 Million | 90.37 Thousand | 153.88 Thousand |
| Net cash flow / Change in cash | 45.11 Million | -3.99 Million | -4.97 Million | -35.91 Million | -135.86 Million | -15.29 Million |
| Free Cash Flow | 48.49 Million | -11.64 Million | -42.9 Million | 47.42 Million | 130.05 Million | 121.32 Million |
BHARATGEAR
ARVN
CPCAF
8446
HSD
WCCP